MUC15 and hepatocellular carcinoma: In this study, we discover that MUC15 was downregulated in liver T-ICs and played an essential role in hepatoma cells self-renewal, malignant proliferation, tumorigenicity, and chemoresistance, suggesting MUC15 is a novel biomarker for liver T-ICs and a potential target for HCC therapy.